In addition to metal acquisition signatures, PAO1 growth in CF sputum is also distinguished from SCFM2 by the activation of GO terms related to LPS biosynthesis, vitamin B biosynthesis, type III secretion, and the DNA damage response (Fig. 1B). The gene discussed is SMOX; the disease is cystic fibrosis.